SCHEMBL9784397

SCHEMBL9784397

CC(=O)c1ccc(C(C2CCCCC2)n2ccnc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 2/20 0.64
CYP11B1 P15538 5/20 0.46
CYP11B2 P19099 5/20 0.46
CYP3A4 P08684 1/20 0.45
BAZ2B Q9UIF8 1/20 0.45
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
EPHX1 P07099 1/20 0.41
CYP19A1 P11511 3/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
DHODH Q02127 1/20 0.39
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19999186 0.80 CYP17A1 (0.67) CYP17A1CYP11B1CYP11B2CYP19A1KMT2A
SCHEMBL9194274 0.77 CYP17A1 (0.67) CYP17A1CYP11B1CYP11B2CYP19A1
SCHEMBL9267609 0.77 CYP17A1 (0.67) CYP17A1CYP11B1CYP11B2CYP19A1
SCHEMBL9192367 0.77 CYP17A1 (0.67) CYP17A1CYP11B1CYP11B2CYP19A1
SCHEMBL9194562 0.77 CYP17A1 (0.67) CYP17A1CYP11B1CYP11B2CYP19A1
SCHEMBL9266596 0.77 CYP17A1 (0.67) CYP17A1CYP11B1CYP11B2CYP19A1
Hydrochloric Acid SCHEMBL9316769 0.76 CYP17A1 (0.65) CYP17A1CYP11B1CYP11B2CYP19A1
SCHEMBL9196681 0.75 CYP17A1 (0.64) CYP17A1CYP11B1CYP11B2CYP19A1
SCHEMBL9192918 0.73 CYP19A1 (0.61) CYP17A1CYP11B1CYP11B2CYP19A1
SCHEMBL2351262 0.72 CYP11B2 (0.57) CYP17A1CYP11B1CYP11B2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0340153-A1 N-substituted imidazoles, process for their preparation and their use in medicaments SCHERING AKTIENGESELLSCHAFT (DE) 1989-11-02 EP claimed
US-5045558-A Aromatase inhibitors, prevention of estrogen biosynthesis, treatment of breast cancer SCHERING AKTIENGESELLSCHAFT (DE) 1991-09-03 US disclosed
EP-0340153-A1 N-substituted imidazoles, process for their preparation and their use in medicaments SCHERING AKTIENGESELLSCHAFT (DE) 1989-11-02 EP disclosed